Childhood vaccines referencing the current Center for Disease Control and Preventions (CDC) Federal Contract for Vaccine and Biologicals. CDC…

GlaxoSmithKline (GSK) has been awarded a state contract by Texas for childhood vaccine procurement, referencing the Centers for Disease Control and Prevention (CDC) Federal Contract Number 75D30125D00198. The contract, identified as HHSTX-6-0000386612, is effective through September 30, 2025, and will facilitate vaccine distribution through the VTrckS (Vaccine Tracking System) purchasing platform. The awarded vaccines encompass multiple immunization types, including vaccines for multiple sclerosis, rabies, rubella, tetanus, and diphtheria.

The contract falls under the NIGP (National Institute of Governmental Purchasing) Code 26980 for Serums, Toxoids, and Vaccines, and includes several specific UNSPSC (United Nations Standard Products and Services Code) categories. The Texas-based contract enables the state's Immunizations, Vaccine Services Group to order vaccines directly, ensuring compliance with CDC guidelines and supporting comprehensive childhood immunization programs. While specific contract value details are not provided, the award represents a structured procurement mechanism for critical public health vaccine resources.